Artificial intelligence in Parkinson's disease: Early detection and diagnostic advancements

被引:6
|
作者
Reddy, Aananya [1 ,2 ]
Reddy, Ruhananhad P. [1 ,2 ]
Roghani, Aryan Kia [1 ,3 ]
Garcia, Ricardo Isaiah [1 ]
Khemka, Sachi [1 ]
Pattoor, Vasanthkumar [1 ,5 ]
Jacob, Michael [1 ,4 ]
Reddy, P. Hemachandra [1 ,6 ,7 ,8 ,9 ]
Sehar, Ujala [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA
[2] Lubbock High Sch, Lubbock, TX 79401 USA
[3] Frenship High Sch, Lubbock, TX 79382 USA
[4] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA
[5] Univ S Florida, Tampa, FL 33620 USA
[6] Texas Tech Univ, Coll Human Med, Hlth Sci Ctr, Nutr Sci Dept, Lubbock, TX 79430 USA
[7] Texas Tech Univ, Hlth Sci Ctr, Publ Hlth Dept, Grad Sch Biomed Sci, Lubbock, TX 79430 USA
[8] Texas Tech Univ, Hlth Sci Ctr, Sch Hlth Profess, Dept pf Speech Language & Hearing Serv, Lubbock, TX 79430 USA
[9] Texas Tech Univ, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA
基金
美国国家卫生研究院;
关键词
Parkinson's disease; Early detectable biomarkers; Therapeutic strategies; Artificial intelligence; Machine learning tools; SOCIOECONOMIC-STATUS; ETHNIC VARIATION; BIOMARKERS; PROGRESSION; POPULATION; PREVALENCE; CONSENT; IMPACT;
D O I
10.1016/j.arr.2024.102410
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Parkinson's disease (PD) is the second most common neurodegenerative disorder, globally affecting men and women at an exponentially growing rate, with currently no cure. Disease progression starts when dopaminergic neurons begin to die. In PD, the loss of neurotransmitter, dopamine is responsible for the overall communication of neural cells throughout the body. Clinical symptoms of PD are slowness of movement, involuntary muscular contractions, speech & writing changes, lessened automatic movement, and chronic tremors in the body. PD occurs in both familial and sporadic forms and modifiable and non-modifiable risk factors and socioeconomic conditions cause PD. Early detectable diagnostics and treatments have been developed in the last several decades. However, we still do not have precise early detectable biomarkers and therapeutic agents/drugs that prevent and/or delay the disease process. Recently, artificial intelligence (AI) science and machine learning tools have been promising in identifying early detectable markers with a greater rate of accuracy compared to past forms of treatment and diagnostic processes. Artificial intelligence refers to the intelligence exhibited by machines or software, distinct from the intelligence observed in humans that is based on neural networks in a form and can be used to diagnose the longevity and disease severity of disease. The term Machine Learning or Neural Networks is a blanket term used to identify an emerging technology that is created to work in the way of a "human brain" using many intertwined neurons to achieve the same level of raw intelligence as that of a brain. These processes have been used for neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, to assess the severity of the patient's condition. In the current article, we discuss the prevalence and incidence of PD, and currently available diagnostic biomarkers and therapeutic strategies. We also highlighted
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Bias Investigation in Artificial Intelligence Systems for Early Detection of Parkinson's Disease: A Narrative Review
    Paul, Sudip
    Maindarkar, Maheshrao
    Saxena, Sanjay
    Saba, Luca
    Turk, Monika
    Kalra, Manudeep
    Krishnan, Padukode R.
    Suri, Jasjit S.
    DIAGNOSTICS, 2022, 12 (01)
  • [2] Explainable artificial intelligence to diagnose early Parkinson's disease via voice analysis
    Shen, Matthew
    Mortezaagha, Pouria
    Rahgozar, Arya
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [3] Advancements in early detection of diabetes and diabetic retinopathy screening using artificial intelligence
    Deepa, R.
    Sivasamy, A.
    AIP ADVANCES, 2023, 13 (11)
  • [4] Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence
    Signaevsky, Maxim
    Marami, Bahram
    Prastawa, Marcel
    Tabish, Nabil
    Iida, Megan A.
    Zhang, Xiang Fu
    Sawyer, Mary
    Duran, Israel
    Koenigsberg, Daniel G.
    Bryce, Clare H.
    Chahine, Lana M.
    Mollenhauer, Brit
    Mosovsky, Sherri
    Riley, Lindsey
    Dave, Kuldip D.
    Eberling, Jamie
    Coffey, Chris S.
    Adler, Charles H.
    Serrano, Geidy E.
    White, Charles L.
    Koll, John
    Fernandez, Gerardo
    Zeineh, Jack
    Cordon-Cardo, Carlos
    Beach, Thomas G.
    Crary, John F.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2022, 10 (01)
  • [5] Antemortem detection of Parkinson’s disease pathology in peripheral biopsies using artificial intelligence
    Maxim Signaevsky
    Bahram Marami
    Marcel Prastawa
    Nabil Tabish
    Megan A. Iida
    Xiang Fu Zhang
    Mary Sawyer
    Israel Duran
    Daniel G. Koenigsberg
    Clare H. Bryce
    Lana M. Chahine
    Brit Mollenhauer
    Sherri Mosovsky
    Lindsey Riley
    Kuldip D. Dave
    Jamie Eberling
    Chris S. Coffey
    Charles H. Adler
    Geidy E. Serrano
    Charles L. White
    John Koll
    Gerardo Fernandez
    Jack Zeineh
    Carlos Cordon-Cardo
    Thomas G. Beach
    John F. Crary
    Acta Neuropathologica Communications, 10
  • [6] Diagnostic aspects of early Parkinson’s disease
    Thomas Müller
    Gerd Fuchs
    Matthias Hahne
    Wolfgang Klein
    Michael Schwarz
    Journal of Neurology, 2006, 253 : iv29 - iv31
  • [7] Diagnostic accuracy in early Parkinson's disease
    Rajput, AH
    Jankovic, J
    McDermott, M
    NEUROLOGY, 1997, 48 (03) : 60001 - 60001
  • [8] Diagnostic aspects of early Parkinson's disease
    Mueller, Thomas
    Fuchs, Gerd
    Hahne, Matthias
    Klein, Wolfgang
    Schwarz, Michael
    JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 4) : 29 - 31
  • [9] Machine Learning based Diagnostic System for Early Detection of Parkinson's Disease
    Saikia, Angana
    Majhi, Vinayak
    Hussain, Masaraf
    Barua, Amit Ranjan
    Paul, Sudip
    Verma, Jitendra Kumar
    2020 INTERNATIONAL CONFERENCE ON COMPUTATIONAL PERFORMANCE EVALUATION (COMPE-2020), 2020, : 275 - 279
  • [10] Artificial Intelligence in Parkinson's Disease Detection: A Strategic Assessment for U.S. Market Entry
    AlSafran, Dannah
    Belhabib, Hind
    Bandah, Amjad
    AlSafran, Sarah
    Homran, Sultanah
    Yusuf, Nadia
    EUROPEAN JOURNAL OF SUSTAINABLE DEVELOPMENT, 2024, 13 (03): : 329 - 343